NCT05569668View on ClinicalTrials.gov

Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma

CompletedOBSERVATIONAL
Enrollment

826

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Esophagus Cancer
Interventions
DRUG

Paclitaxel- and platinum-based chemotherapy

Neoadjuvant Chemotherapy

Trial Locations (1)

450003

Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV

NCT05569668 - Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma | Biotech Hunter | Biotech Hunter